Roth Capital Maintains Buy on Imax, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 62.1%

Neg 0% Neu 0% Pos 62.1%

Roth Capital analyst Eric Handler maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $50 to $60.

Comments

No comments yet. Be the first!